Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Holdings

2,370.44
+27.551.18%
Number of Gainers:70
Number of Losers:25
Number of Flat:2
PE:- -
High:2,375.42
Open:2,342.75
Low:2,342.75
Close:2,342.89
Volume:1.24B
Turnover:296.86B
Market Cap:52.59T
Float Cap:49.22T

Loading ...

Sector Update: Tech Stocks Rise Late Afternoon

MT Newswires Live
·
Aug 26

Looking for a Bottom in Dick’s and Nike Stocks? Here’s What Wall Street Thinks

TIPRANKS
·
Aug 26

U.S. Earnings Preview: After Market Close Aug. 25

Dow Jones
·
Aug 26

Nvidia Stock (NVDA) Expected to Move 5% After Earnings

TIPRANKS
·
Aug 26

Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor

MT Newswires Live
·
Aug 26

Sea Ltd Stock (SE) Moved Up by 6.58% on Aug 25: What Signal Does It Send?

TradingKey
·
Aug 26

Nvidia's Upcoming Earnings Report Expected to Show Revenue Growth Outpacing Most Rivals

Deep News
·
Aug 26

NASDAQ Leads Stocks Higher in Final Hour as Nvidia Earnings, Inflation Data Loom

Dow Jones
·
Aug 26

U.S. Federal Communications Commission Says Joint Fundraising Committees, Party Committees Can Purchase Advertising TV Air Time at Discount Previously Allowed Only for Candidates

THOMSON REUTERS
·
Aug 26

This Chart Shows Exactly Why Investors Should Worry About Rising Yields - Even if They Don't Own Any Bonds

Dow Jones
·
Aug 26

Abbott receives FDA authorization for Libre Duo 10 Day system

TIPRANKS
·
Aug 26

Abbott - to Launch Libre Duo 10 Day in U.S. Later This Year

THOMSON REUTERS
·
Aug 26

Abbott Receives FDA Authorization for World's First Dual Glucose-Ketone Sensing Technology for People with Diabetes

THOMSON REUTERS
·
Aug 26

Eli Lilly Stock (LLY) Rattled as Companies Decline to Cover Weight-Loss Drug Costs

TIPRANKS
·
Aug 26

Intuit Drops in Volume Spike, Shares Last Down 3.1%

THOMSON REUTERS
·
Aug 26

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

Reuters
·
Aug 26

FDA :Granted Marketing Authorization to Abbott Diabetes Care for Libre Duo 10 Day Through De Novo Premarket Review Pathway

THOMSON REUTERS
·
Aug 26

Hold Rating Maintained as Strong Operations Offset Weaker Free Cash Flow and Price Target Trim to A$32.70

TIPRANKS
·
Aug 26

Morgan Stanley views Precision Medicine as logical addition to McKesson platform

TIPRANKS
·
Aug 26

Cboe data shows mixed options sentiment in Alphabet with shares down 0.48%

TIPRANKS
·
Aug 26